Katarzyna Medyńska

Spearheaded independent research tasks for a national grant (NCN OPUS 20), ensuring adherence to project timelines and scientific objectives.

Developed robust research methodologies based on comprehensive literature analysis, optimizing experimental design for scientific validity and reproducibility.

Performed advanced data analysis using specialized tools and prepared high-quality scientific outputs, contributing to research dissemination.

Achieved an impressive 89% sales growth for Cyclo3Fort, increasing units from 2492 to 4714, significantly exceeding regional targets.

Consistently ranked as a top performer in internal sales reports, demonstrating exceptional contribution to overall team objectives and market share.

Strategically expanded product presence across a diverse territory, introducing key offerings to GPs, pediatricians, surgeons, gynecologists, ENT, and pulmonology specialists.

Delivered high-impact medical presentations and educational meetings to physician groups, effectively translating complex scientific data into clinical value.

Managed territory independently, optimizing visit planning and resource allocation to maximize physician engagement and product awareness.

Executed detailed research on liposomal drug formulations for oncology applications, contributing to advancements in targeted drug delivery systems.

Managed and maintained mammalian cell cultures under strict sterile laboratory conditions, ensuring integrity for experimental protocols and reliable results.

Analyzed experimental data and prepared comprehensive research reports, providing critical insights into drug formulation efficacy and safety profiles.